One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Front Cover
Lixin Guo MD, Fengsheng Tian MM, Li Liu MM, Mingwei Chen MD, Chengxia Jiang BS, Shuangqing Li MM, Cong Liu MD, Yawei Zhang BS, Jie Qin MD, Dongni Yu MM, Yicen Zong MM, Wei Dai PhD
doi : 10.1111/dom.15720
Volume 26, Issue 7
The need for registry-based studies in diabetes and stroke: A unique opportunity to understand whether diabetic treatments improve post-stroke outcome
Vladimer Darsalia PhD, Ellen Vercalsteren PhD, Dimitra Karampatsi MSc, Mihaela Oana Romanitan MD, Michael V. Mazya MD, Thomas Nyström MD, Cesare Patrone PhD
doi : 10.1111/dom.15577
An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management
Mehmet Kanbay MD, Sidar Copur MD, A. Umur Topçu MD, Mustafa Guldan MD, Lasin Ozbek MD, Abduzhappar Gaipov MD, Charles Ferro MD, Mario Cozzolino MD, David Z. I. Cherney MD, Katherine R. Tuttle MD
doi : 10.1111/dom.15575
A commentary review on endoscopic sleeve gastroplasty: Indications, outcomes and future implications
Mahmoud Abuawwad BM, Ameya Tibude MBBS, Devinder Bansi BM, Iskandar Idris BMBS, Brijesh Madhok MBBS
doi : 10.1111/dom.15613
The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and death
Alexander Lynge Reese-Petersen PhD, Signe Holm Nielsen PhD, Jannie Marie Bülow Sand PhD, Jörn M. Schattenberg MD, Elisabetta Bugianesi MD, Morten A. Karsdal PhD
doi : 10.1111/dom.15615
Cardiorenal outcomes and mortality after sodium-glucose cotransporter-2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history
Jin Hwa Kim MD, Young Sang Lyu MD, BongSeong Kim PhD, Mee Kyung Kim MD, Sang Yong Kim MD, Ki-Hyun Baek MD, Ki-Ho Song MD, Kyungdo Han PhD, Hyuk-Sang Kwon MD
doi : 10.1111/dom.15565
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis
Khawaja M. Talha MBBS, Jennifer Green MD, Gerasimos Filippatos MD, Stuart Pocock PhD, Faiez Zannad MD, Martina Brueckmann MD, Elke Schueler, Anne Pernille Ofstad MD, João Pedro Ferreira MD, Stefan D. Anker MD, Javed Butler MD, Julio Rosenstock MD, Milton Packer MD
doi : 10.1111/dom.15572
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes
Sae Im Jeong MD, Mu Seong Ban MD, Jun-Gi Hwang MD, Min-Kyu Park MD, Soo Lim MD, Sejoong Kim MD, Soon Kil Kwon MD, Yoonjin Kim MD, Jae Min Cho PhD, Jae Jin Na BS, Wan Huh MS, Jae-Yong Chung MD
doi : 10.1111/dom.15573
Healthy Outcomes through Peer Educators: Feasibility of a peer support diabetes prevention programme for African-American grandmother caregivers
Eva M. Vivian PharmD, Betty A. Chewning PhD, Corrine I. Voils PhD, Roger L. Brown PhD
doi : 10.1111/dom.15574
Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated database
Matthew Anson MBBS, Alex E. Henney MBChB, Sizheng S. Zhao PhD, Gema H. Ibarburu PhD, Gregory Y. H. Lip PhD, Daniel J. Cuthbertson PhD, Katarzyna Nabrdalik PhD, Uazman Alam PhD
doi : 10.1111/dom.15576
Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes
Krzysztof Irlik, Hanadi Aldosari MSc, Mirela Hendel, Hanna Kwiendacz PhD, Julia PiaÅ›nik, Justyna Kulpa, PaweÅ‚ Ignacy MBBS, Sylwia Boczek, MikoÅ‚aj Herba, Kamil Kegler, Frans Coenen PhD, Janusz Gumprecht PhD, Yalin Zheng PhD, Gregory Y. H. Lip MD, Uazman Alam PhD, Katarzyna Nabrdalik PhD … See fewer authorsÂ
doi : 10.1111/dom.15578
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity
Rajna Golubic MD, Jane Kennet RN, Victoria Parker MBBS, Darren Robertson PhD, Dan Luo PhD, Lars Hansen MD, Lutz Jermutus MD, Phil Ambery MBChB, Maria Ryaboshapkina MS, Manasa Surakala MTech, Rhianna C. Laker PhD, Michelle Venables PhD, Albert Koulman PhD, Adrian Park MBBS, Mark Evans MD … See fewer authorsÂ
doi : 10.1111/dom.15579
Combined intake of caffeine and low-dose glucose to reduce exercise-related hypoglycaemia in individuals with type 1 diabetes on ultra-long-acting insulin degludec: A randomized, controlled, double-blind, cross-over trial
Tobias Kühne MD, Esmè Wallace MS, David Herzig PhD, Simon Helleputte PhD, Sam Scott PhD, Jordan Pickles PhD, Andreas Melmer MD, Christoph Stettler MD
doi : 10.1111/dom.15580
Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta-analysis of randomized controlled trials
Gabriel Grando Alves, Luisa Cunha MD, Rafael Henkes Machado, Vanessa Lins de Menezes MD
doi : 10.1111/dom.15581
Sleep duration and association with cardiometabolic health in adolescents and adults with type 1 diabetes: Results from the BCQR-T1D study
Stacey L. Simon PhD, Janet K. Snell-Bergeon PhD, Michal Schäfer PhD, Alex J. Barker PhD, Lorna P. Browne MD, Uyen Truong MD, Shoshana S. Tell MD, Timothy Vigers MS, Amy D. Baumgartner MS, Ellen Lyon PhD, Sarit Polsky MD, Irene E. Schauer MD, Kristen J. Nadeau MS … See fewer authorsÂ
doi : 10.1111/dom.15582
Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study
Ze-Gui Huang PhD, Jing-Wei Gao PhD, Hai-Feng Zhang PhD, Si You MD, Zhuo-Chao Xiong PhD, Yu-Biao Wu MD, Da-Chuan Guo MD, Jing-Feng Wang PhD, Yang-Xin Chen PhD, Shao-Ling Zhang PhD, Pin-Ming Liu PhD … See fewer authorsÂ
doi : 10.1111/dom.15583
Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population-based cohort study
Fatema Mahmoud PhD, Tanja Mueller PhD, Alexander Mullen PhD, Christopher Sainsbury MD, Gordon F. Rushworth PhD, Amanj Kurdi PhD
doi : 10.1111/dom.15584
Gamma-aminobutyric acid supplementation improves olanzapine-induced insulin resistance by inhibiting macrophage infiltration in mice subcutaneous adipose tissue
Lulu Ren MD, Lingling Xuan MD, Anning Li MD, Yaqi Yang MS, Wen Zhang MD, Jie Zhang MD, Yi Zhang MD, Zhuoling An MD
doi : 10.1111/dom.15585
The effect of sodium-glucose cotransporter-2 inhibitors on inflammatory biomarkers: A meta-analysis of randomized controlled trials
Leonardo Buttice BSc, Maryam Ghani BSc, Janahan Suthakar BSc, Sathyan Gnanalingham BSc, Elliott Carande BM BCh, Brett W. C. Kennedy BM BCh, Alex Pitcher BM BCh, James H. P. Gamble MD, Mahmood Ahmad MBBS, Andrew Lewis DPhil, Peter Jüni MD, Oliver J. Rider DPhil, Jeffrey W. Stephens PhD, Jonathan J. H. Bray MBChB … See fewer authorsÂ
doi : 10.1111/dom.15586
Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non-interventional study in Kenya
Tom White PhD, Viknesh Selvarajah PhD, Fredrik Wolfhagen-Sand PhD, Nils Svangård MSc, Gayathri Mohankumar MS, Peter Fenici MD, Kathryn Rough ScD, Nelson Onyango PhD, Kendall Lyons MPH, Christina Mack PhD, Videlis Nduba PhD, Mansoor Noorali Saleh MD, Innocent Abayo BSc, Afrah Siddiqui MBBS, Malgorzata Majdanska-Strzalka MPharm, Katarzyna Kaszubska PhD, Tove Hegelund-Myrback PhD, Russell Esterline PhD, Antonio Manzur BS, Victoria E. R. Parker PhD
doi : 10.1111/dom.15587
Improved glycaemic control induced by evening activity breaks does not persist overnight amongst healthy adults: A randomized crossover trial
Jennifer T. Gale MDiet, Jillian J. Haszard PhD, Meredith C. Peddie PhD
doi : 10.1111/dom.15589
Prediction of new-onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS
Fatema Said MD, Clare Arnott MD, Adriaan A. Voors MD, Hiddo J. L. Heerspink MD, Jozine M. ter Maaten MD
doi : 10.1111/dom.15592
Time trends and regional variation in utilization of antidiabetic medicines in China, 2015–2022
Jieqiong Zhang, Sen Xu PhD, Xingyu Liu, Jinwei Zhang, Shuchen Hu, Xiaoyong Liu, Caijun Yang PhD, Yu Fang PhD
doi : 10.1111/dom.15594
C-peptide index at 2 h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes
Yuichiro Iwamoto MD, Tomohiko Kimura MD, Masashi Shimoda MD, Yuichi Morimoto MD, Yuki Watanabe MD, Takashi Itoh MD, Taku Sasaki MD, Shigehito Mori MD, Masato Kubo MD, Haruka Takenouchi MD, Kazunori Dan MD, Hideyuki Iwamoto MD, Junpei Sanada MD, Yoshiro Fushimi MD, Yukino Katakura MD, Shuhei Nakanishi MD, Tomoatsu Mune MD, Kohei Kaku MD, Hideaki Kaneto MD
doi : 10.1111/dom.15595
Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial
Yao Wang MM, Chengxia Jiang MB, Xiaolin Dong MD, Mingwei Chen MD, Qin Gu MM, Lihui Zhang MM, Yanqin Fu MM, Tianrong Pan MM, Yan Bi MD, Weihong Song MB, Jing Xu MA, WeiPing Lu MD, Xiaodong Sun MD, Zi Ye MD, Danli Zhang MM, Liang Peng MD, Xiang Lin MA, Wei Dai PhD, Quanren Wang PhD, Wenying Yang MD
doi : 10.1111/dom.15596
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia
Juliana de Oliveira Costa PhD, Jialing Lin PhD, Tamara Y. Milder FRACP, Jerry R. Greenfield FRACP, Richard O. Day FRACP, Sophie L. Stocker PhD, Brendon L. Neuen PhD, Alys Havard PhD, Sallie-Anne Pearson PhD, Michael O. Falster PhD
doi : 10.1111/dom.15597
Investigating the causal association of generalized and abdominal obesity with microvascular complications in patients with type 2 diabetes: A community-based prospective study
Jiaheng Chen MM, Yu Ting Li MPH, Zimin Niu MM, Zhanpeng He MD, Yao Jie Xie PhD, Jose Hernandez DPhil, Wenyong Huang MD, Harry H X Wang PhD, The Guangzhou Diabetic Eye Study Group
doi : 10.1111/dom.15598
Real-world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12-month, prospective observational study
Rayaz A. Malik PhD, Chii-Min Hwu MD, Anwar A. Jammah MD, Juan M. Arteaga-DÃaz MD, Khier Djaballah MD, Valerie Pilorget MD, Agustina Alvarez MD, Carine Vera PhD, Olga Vikulova PhD
doi : 10.1111/dom.15599
Association of single-point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes
Simin Deng MD, Xinqun Hu MD, Xiangyu Zhang MD
doi : 10.1111/dom.15600
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
Lixin Guo MD, Fengsheng Tian MM, Li Liu MM, Mingwei Chen MD, Chengxia Jiang BS, Shuangqing Li MM, Cong Liu MD, Yawei Zhang BS, Jie Qin MD, Dongni Yu MM, Yicen Zong MM, Wei Dai PhD
doi : 10.1111/dom.15601
A meta-analysis of the association between RBP4 rs3758539 genotype and metabolic syndrome factors
Wen-Chieh Wu PhD, Pei-Yu Wu PhD, Ming-Fen Lee PhD, Chin-Ming Chang MS, Chien-Yi Chan PhD, Chun-Yin Huang PhD
doi : 10.1111/dom.15602
Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank
Ying Hu MD, Xiang Li MD, Xuan Wang MD, Hao Ma MD, Jian Zhou MD, Rui Tang MS, Minghao Kou MHS, Yoriko Heianza PhD, Zhaoxia Liang MD, Lu Qi MD
doi : 10.1111/dom.15603
Biotransformation and disposition characteristics of HSK7653, a novel long-acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Yi-cong Bian MS, Jian Meng PhD, Tao Hu MS, Sheng Ma MS, Chen-rong Huang PhD, Feng-yi Zhang MD, Qing-he Wu MD, Hua Zhang MS, Xiao-yan Chen PhD, Li-yan Miao MD
doi : 10.1111/dom.15605
Association of lifestyle with reduced stroke risk in 41 314 individuals with diabetes: Two prospective cohort studies in China
Jian Su MM, Xikang Fan PhD, Mengyao Li MB, Hao Yu PhD, Houyue Geng MB, Yu Qin PhD, Yan Lu MM, Pei Pei MB, Dianjianyi Sun PhD, Canqing Yu PhD, Jun Lv PhD, Ran Tao PhD, Jinyi Zhou MM, Hongxia Ma PhD, Ming Wu PhD
doi : 10.1111/dom.15606
Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial
Joseph Reed MD, Tony Dong MD, Elke Eaton RN, Janice Friswold RDN, Jodie Porges MS, Sadeer G. Al-Kindi MD, Sanjay Rajagopalan MD, Ian J. Neeland MD
doi : 10.1111/dom.15608
Adiposity indicators exhibit depot- and sex-specific associations with multimorbidity onset: A cohort study of the UK Biobank
Lu Ma PhD, Ying Li MD, Gaixia Li MD, Jiajun Sun MD, Xueli Zhang PhD, Zumin Shi PhD, Yating Yan MD, Yutian Duan BA, Jing Wang PhD, Zengbin Li MD, Lei Zhang PhD
doi : 10.1111/dom.15610
Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database
Tomohiko Kanaoka MD, Hiromichi Wakui MD, Yuichiro Yano MD, Hajime Nagasu MD, Hiroshi Kanegae BSc, Masaomi Nangaku MD, Yosuke Hirakawa MD, Naoki Nakagawa MD, Jun Wada MD, Kazuhiko Tsuruya MD, Toshiaki Nakano MD, Shoichi Maruyama MD, Takashi Wada MD, Masaaki Konishi MD, Takanori Nagahiro MD, Kunihiro Yamagata MD, Ichiei Narita MD, Motoko Yanagita MD, Yoshio Terada MD, Shinichi Araki MD, Masanori Emoto MD, Hirokazu Okada MD, Yoshitaka Isaka MD, Yusuke Suzuki MD, Takashi Yokoo MD, Hiromi Kataoka PhD, Eiichiro Kanda MD, Naoki Kashihara MD, Kouichi Tamura MD, for the J-CKD-DB investigators … See fewer authorsÂ
doi : 10.1111/dom.15611
Association of gestational diabetes with long-term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank
Moscho Michalopoulou DPhil (Oxon), Carmen Piernas PhD, Susan A. Jebb PhD, Min Gao PhD, Nerys M. Astbury PhD
doi : 10.1111/dom.15612
Cross-sectional, case-control and longitudinal associations between exposure to glucagon-like peptide-1 receptor agonists and the dispensing of antidepressants
Osvaldo P. Almeida PhD, Zheng Fong MBBS, Lydia M. Hill Almeida MD, Frank M. Sanfilippo PhD, Amy Page PhD, Christopher Etherton-Beer PhD
doi : 10.1111/dom.15616
Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020
Shanshan Li MS, Shaoxi Pan BS, Shaoxiang Jiang PhD, Jung-Im Shin MD, Gordon G. Liu PhD, Beini Lyu MD
doi : 10.1111/dom.15619
Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1–4 trials
Domenica Rubino MD, Jakob B. Bjorner MD, Naveen Rathor MD, Arya M. Sharma MD, Lisa von Huth Smith PhD, Sean Wharton MD, Thomas Wadden PhD, Niels Zeuthen MSc, Ronette L. Kolotkin PhD
doi : 10.1111/dom.15620
Adenosine kinase inhibits β-cell proliferation by upregulating DNA methyltransferase 3A expression
Ting Chen MD, Jiayu Yu MD, Xin Guo PhD, Siqi Wang MD, Zhihua Wang MD, Yang Chen MD, Xiang Hu MD, Huiqing Li MD, Lulu Chen MD, Juan Zheng MD
doi : 10.1111/dom.15621
Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3-year prospective cohort study
Ming-Ling Chang MD, Jennifer Tai MD, Jur-Shan Cheng PhD, Wei-Ting Chen MD, Sien-Sing Yang MD, Cheng-Hsun Chiu MD, Rong-Nan Chien MD
doi : 10.1111/dom.15622
Real-world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus
Lixin Guo MD, Yue Xi MD, Li Li MD, Kunquan Guo MD, Jun Wu MD, Jiawei Xu MD, Yihua Wang MD, Guangyu Wu MD, Si Si MD
doi : 10.1111/dom.15590
Effectiveness and care continuity in an app-based, glucagon-like peptide-1 receptor agonist-supported weight-loss service for women with overweight and obesity in the UK: A real-world retrospective cohort analysis
Louis Talay PhD, Matt Vickers MD
doi : 10.1111/dom.15607
Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use
Jochen Seufert MD, Nick Freemantle PhD, Cristian Guja MD, Martin HaluzÃk MD, Mathilde Tournay MS, Carine Vera PhD, Mireille Bonnemaire MD, Janos T. Kis MD
doi : 10.1111/dom.15609
Body mass index and remote ischaemic conditioning efficacy in acute ischaemic stroke patients: A post hoc analysis of the Remote Ischaemic Conditioning for Acute Moderate Ischaemic Stroke (RICAMIS) trial
Xiao-Yu Sun MD, Hui-Ling Qu MD, Hui-Sheng Chen MD
doi : 10.1111/dom.15614
A comment on ‘Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials’
Ronald M. Goldenberg MD
doi : 10.1111/dom.15588
Correction to “Defining diabetes status using medication groups in Medicare data: Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time�
doi : 10.1111/dom.15618
